USPTO 2015–2025 USPTO PatentsView US Corporation

Extremity Medical, LLC

USPTO PatentsView assignee record - 26 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Extremity ranks #11,645 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 4 technology areas.

#11,645
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.5/100)
22.2
avg claims per patent
-8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11645 · US Corporation #11,645 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 26 grants
  • UPPER-Q #11,645/49,997
  • PHOTO-FINISH EnergyHub
  • CPC-NARROW A61B · 4 areas
  • INNOV-THIN 37.5/100
  • CLAIMS-DENSE 22.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT -8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: EnergyHub, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Extremity’s 37.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Extremity

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Extremity's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Extremity?

Each dot is one of Extremity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Extremity’s own 22.2 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Extremity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 25.92626.1 510152025 Granted patents (volume) Avg claims / patent EnergyHub, Inc. - 26, 20.58EnergyhubEnsco International Incorporated - 26, 18.65Ensco Internation…Estimote Polska Sp z o.o. - 26, 16.65Estimote Polska S…ExploraMed NC7, Inc. - 26, 12.04Exploramed NC7Fabbrica D'armi Pietro Beretta S.P.A. - 26, 9.27Fabbrica D'armi P…Facet Technologies, LLC - 26, 15.27FacetFirst American Financial Corporation - 26, 18.69First American Fi…Fosbel, Inc. - 26, 8.19FosbelExtremity Medical, LLC - 26, 22.19Extremity Medical
Extremity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Extremity's grants concentrate

Extremity Medical, LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2018. By volume, Extremity sits between EnergyHub, Inc. and Fosbel, Inc..

Extremity's three-year grant acceleration

Extremity Medical, LLC shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Extremity's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Extremity holds 26 patents at rank #11,645, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Extremity

By rank, the assignees closest to #11,645 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Extremity's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Extremity, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Extremity ranks #709 of 7,127 assignees by patent count in that subclass.

Extremity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620172018201920202021202220242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Extremity Medical, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 11.5%
2016 4 15.4%
2017 2 7.7%
2018 1 3.8%
2019 2 7.7%
2020 2 7.7%
2021 3 11.5%
2022 1 3.8%
2024 5 19.2%
2025partial year 3 11.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Extremity Medical, LLC's patent record in context - here's where to go next.

  • Extremity Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #11,645 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Extremity Medical, LLC against EnergyHub, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.